The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients

Overview of attention for article published in Frontiers in oncology, October 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 26,086 followers.

New article: The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients https://t.co/PoYg2V46ai #MMSM #MultipleMyeloma #hematology https://t.co/h82BPY77Ut

24 Oct 2022

Reply Repost Favourite

The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients: Objective 1q21 gain/amplification (1q21+) is a common abnormal karyotype in multiple myeloma, and its… #oncology https://t.co/4Dik8bqn

10 Oct 2022

Reply Repost Favourite

New research: The independent adverse prognostic significance of 1q21 gain/amplification in newly diagnosed multiple myeloma patients: Objective 1q21 gain/amplification (1q21+) is a common abnormal karyotype in multiple myeloma, and its… https://t.co/URPf

07 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.